Verition Fund Management LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$327,327
+2.0%
13,748
+65.6%
0.00%
-33.3%
Q2 2022$321,000
-56.3%
8,303
-35.3%
0.01%
-33.3%
Q1 2022$735,000
+45.3%
12,824
+101.9%
0.01%
+125.0%
Q4 2021$506,000
+49.7%
6,353
+63.7%
0.00%
+33.3%
Q3 2021$338,000
-58.2%
3,881
-38.2%
0.00%
-57.1%
Q2 2021$808,0006,2810.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders